Literature DB >> 31515709

Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents.

Lidija Senerovic1, Dejan Opsenica2,3, Ivana Moric4, Ivana Aleksic4, Marta Spasić5, Branka Vasiljevic4.   

Abstract

Infective diseases have become health threat of a global proportion due to appearance and spread of microorganisms resistant to majority of therapeutics currently used for their treatment. Therefore, there is a constant need for development of new antimicrobial agents, as well as novel therapeutic strategies. Quinolines and quinolones, isolated from plants, animals, and microorganisms, have demonstrated numerous biological activities such as antimicrobial, insecticidal, anti-inflammatory, antiplatelet, and antitumor. For more than two centuries quinoline/quinolone moiety has been used as a scaffold for drug development and even today it represents an inexhaustible inspiration for design and development of novel semi-synthetic or synthetic agents exhibiting broad spectrum of bioactivities. The structural diversity of synthetized compounds provides high and selective activity attained through different mechanisms of action, as well as low toxicity on human cells. This review describes quinoline and quinolone derivatives with antibacterial, antifungal, anti-virulent, antiviral, and anti-parasitic activities with the focus on the last 10 years literature.

Entities:  

Keywords:  Anti-parasitics; Anti-virulence activity; Antibiotics; Antifungals; Antivirals; Quinoline/quinolone derivatives

Mesh:

Substances:

Year:  2020        PMID: 31515709     DOI: 10.1007/5584_2019_428

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone.

Authors:  Bashir Lawal; Yu-Cheng Kuo; Maryam Rachmawati Sumitra; Alexander T H Wu; Hsu-Shan Huang
Journal:  Comput Biol Med       Date:  2022-07-11       Impact factor: 6.698

2.  Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes.

Authors:  Vineela Parvathaneni; Rasha S Elbatanony; Mimansa Goyal; Tejashri Chavan; Nathan Vega; Srikanth Kolluru; Aaron Muth; Vivek Gupta; Nitesh K Kunda
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

3.  A study of structure-activity relationship and anion-controlled quinolinyl Ag(I) complexes as antimicrobial and antioxidant agents as well as their interaction with macromolecules.

Authors:  Adesola A Adeleke; Sizwe J Zamisa; Md Shahidul Islam; Kolawole Olofinsan; Veronica F Salau; Chunderika Mocktar; Bernard Omondi
Journal:  Biometals       Date:  2022-03-11       Impact factor: 2.949

4.  5-((1H-imidazol-1-yl)methyl)quinolin-8-ol as potential antiviral SARS-CoV-2 candidate: Synthesis, crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies.

Authors:  Dhaybia Douche; Yusuf Sert; Silvia A Brandán; Ameed Ahmed Kawther; Bayram Bilmez; Necmi Dege; Ahmed El Louzi; Khalid Bougrin; Khalid Karrouchi; Banacer Himmi
Journal:  J Mol Struct       Date:  2021-01-27       Impact factor: 3.196

5.  Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review.

Authors:  Anna Caroline Campos Aguiar; Julia Risso Parisi; Renata Neves Granito; Lorena Ramos Freitas de Sousa; Ana Cláudia Muniz Renno; Marcos Leoni Gazarini
Journal:  Mar Drugs       Date:  2021-02-28       Impact factor: 5.118

6.  Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.

Authors:  Onat Kadioglu; Mohamed Saeed; Henry Johannes Greten; Thomas Efferth
Journal:  Comput Biol Med       Date:  2021-03-30       Impact factor: 6.698

7.  Preliminary Studies of Antimicrobial Activity of New Synthesized Hybrids of 2-Thiohydantoin and 2-Quinolone Derivatives Activated with Blue Light.

Authors:  Agnieszka Kania; Waldemar Tejchman; Anna M Pawlak; Krystian Mokrzyński; Bartosz Różanowski; Bogdan M Musielak; Magdalena Greczek-Stachura
Journal:  Molecules       Date:  2022-02-05       Impact factor: 4.411

8.  A High-Throughput Phenotypic Screen of the 'Pandemic Response Box' Identifies a Quinoline Derivative with Significant Anthelmintic Activity.

Authors:  Harrison T Shanley; Aya C Taki; Joseph J Byrne; Abdul Jabbar; Tim N C Wells; Kirandeep Samby; Peter R Boag; Nghi Nguyen; Brad E Sleebs; Robin B Gasser
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-21

9.  Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel hLDHA Inhibitors.

Authors:  Iván Díaz; Sofia Salido; Manuel Nogueras; Justo Cobo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24

10.  Sensitivity of different DNA extraction methods and PCR to detect resistance in patients with leprosy stratified by the bacilloscopic index.

Authors:  Lais Sevilha-Santos; Danielle Costa Aquino; Günter Hans Neto; Fabiano José Queiroz Costa; Carlos Augusto Felipe de Sousa; Elaine Faria Morelo; Agenor de Castro Moreira Dos Santos Júnior; Ciro Martins Gomes
Journal:  Braz J Infect Dis       Date:  2022-06-27       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.